These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37553247)

  • 1. Common variable immunodeficiency disorder (CVID)-related liver disease: assessment of the main histological aspects using novel semiquantitative scoring systems, image analysis and correlation with clinical parameters of liver stiffness and portal hypertension.
    Silva H; Brito CGX; Hall A; Eden N; Somers H; Burke N; Burns SO; Lowe D; Thorburn D; Halliday N; Quaglia A
    J Clin Pathol; 2024 Sep; 77(10):709-716. PubMed ID: 37553247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of Hepatic Manifestations of Common Variable Immunodeficiency.
    Crotty R; Taylor MS; Farmer JR; Kakar S; Yilmaz F; Ardeniz Ö; Patil DT; Deshpande V
    Am J Surg Pathol; 2020 May; 44(5):617-625. PubMed ID: 32187043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Stiffness by Transient Elastography Correlates With Degree of Portal Hypertension in Common Variable Immunodeficiency Patients With Nodular Regenerative Hyperplasia.
    DiGiacomo DV; Shay JE; Crotty R; Yang N; Bloom P; Corey K; Barmettler S; Farmer JR
    Front Immunol; 2022; 13():864550. PubMed ID: 35603209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular regenerative hyperplasia in common variable immunodeficiency.
    Fuss IJ; Friend J; Yang Z; He JP; Hooda L; Boyer J; Xi L; Raffeld M; Kleiner DE; Heller T; Strober W
    J Clin Immunol; 2013 May; 33(4):748-58. PubMed ID: 23420139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal hypertension in common variable immunodeficiency disorders - a single center analysis on clinical and immunological parameter in 196 patients.
    Hanitsch LG; Steiner S; Schumann M; Wittke K; Kedor C; Scheibenbogen C; Fischer A
    Front Immunol; 2023; 14():1268207. PubMed ID: 38187397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis.
    Rodrigues SG; Montani M; Guixé-Muntet S; De Gottardi A; Berzigotti A; Bosch J
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2101-2109.e1. PubMed ID: 30625404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver disease accompanied by enteropathy in common variable immunodeficiency: Common pathophysiological mechanisms.
    Lima FMS; Toledo-Barros M; Alves VAF; Duarte MIS; Takakura C; Bernardes-Silva CF; Marinho AKBB; Grecco O; Kalil J; Kokron CM
    Front Immunol; 2022; 13():933463. PubMed ID: 36341360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variable immunodeficiency disorder-related liver disease is common and results in portal hypertension and an increased risk of death.
    Halliday N; Eden N; Somers H; Burke N; Silva H; Brito CG; Hall A; Quaglia A; Burns SO; Lowe DM; Thorburn D
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38099861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nodular regenerative hyperplasia associated with common variable immunodeficiency and other comorbidities].
    León R; Sánchez-Martínez R; Palazón JM; Payá A; Ramos JM; Pinargote H
    Med Clin (Barc); 2016 Mar; 146(6):263-6. PubMed ID: 26723943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver.
    Laharie D; Vergniol J; Bioulac-Sage P; Diris B; Poli J; Foucher J; Couzigou P; Drouillard J; de Lédinghen V
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):487-93. PubMed ID: 19940782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.
    Malamut G; Ziol M; Suarez F; Beaugrand M; Viallard JF; Lascaux AS; Verkarre V; Bechade D; Poynard T; Hermine O; Cellier C
    J Hepatol; 2008 Jan; 48(1):74-82. PubMed ID: 17998147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhosis histology and Laennec staging system correlate with high portal pressure.
    Rastogi A; Maiwall R; Bihari C; Ahuja A; Kumar A; Singh T; Wani ZA; Sarin SK
    Histopathology; 2013 Apr; 62(5):731-41. PubMed ID: 23470026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild changes of hepatic nodular regenerative hyperplasia may cause portal hypertension and be visible on reticulin but not hematoxylin and eosin staining.
    Navale P; Gonzalez RS
    Virchows Arch; 2021 Dec; 479(6):1145-1152. PubMed ID: 34435237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of hepatic fibrosis in common variable immunodeficiency-related porto-sinusoidal vascular disorder.
    Hercun J; Asif B; Vittal A; Ahmed A; Gopalakrishna Pillai HK; Bergerson JRE; Holland S; Uzel G; Strober W; Fuss IJ; Koh C; Kleiner DE; Heller T
    Aliment Pharmacol Ther; 2024 Aug; ():. PubMed ID: 39090843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease.
    Daza-Cajigal V; Segura-Guerrero M; López-Cueto M; Robles-Marhuenda Á; Camara C; Gerra-Galán T; Gómez-de-la-Torre R; Avendaño-Monje CL; Sánchez-Ramón S; Bosque-Lopez MJ; Quintero-Duarte A; Bonet-Vidal ML; Pons J
    Front Immunol; 2023; 14():1197361. PubMed ID: 37342345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency.
    Globig AM; Strohmeier V; Surabattula R; Leeming DJ; Karsdal MA; Heeg M; Kindle G; Goldacker S; von Spee-Mayer C; Proietti M; Bausch B; Bettinger D; Schultheiß M; Thimme R; Schuppan D; Warnatz K
    J Clin Immunol; 2022 Nov; 42(8):1626-1637. PubMed ID: 35821451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of the endothelial genes Notch1 and ephrinB2 in patients with nodular regenerative hyperplasia.
    Rothweiler S; Terracciano L; Tornillo L; Dill MT; Heim MH; Semela D
    Liver Int; 2014 Apr; 34(4):594-603. PubMed ID: 23870033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.
    Barge S; Grando V; Nault JC; Broudin C; Beaugrand M; Ganne-Carrié N; Roulot D; Ziol M
    Liver Int; 2016 Jul; 36(7):1059-66. PubMed ID: 26415006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular regenerative hyperplasia - An under-recognized vascular disorder of liver.
    Bakshi N; Gulati N; Rastogi A; Chougule A; Bihari C; Jindal A
    Pathol Res Pract; 2020 Apr; 216(4):152833. PubMed ID: 32164988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of hepatic steatosis on portal hypertension.
    Semmler G; Scheiner B; Schwabl P; Bucsics T; Paternostro R; Chromy D; Stättermayer AF; Trauner M; Mandorfer M; Ferlitsch A; Reiberger T
    PLoS One; 2019; 14(11):e0224506. PubMed ID: 31693695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.